Publication | Closed Access

Quantitative and qualitative pleiotropic differences between Simvastatin single and Vytorin combination therapy in hypercholesterolemic subjects

ThrombosisHypertensionCardiovascular DiseasePharmacologyVytorin Combination TherapyVascular BiologyPharmacotherapyHypercholesterolemic SubjectsHyperlipidemiaMedicineAtherosclerosisDyslipidemiaCoronary Artery DiseaseQualitative Pleiotropic Differences